Guangxi Huayi acrylic device feeding success
On December 19, Guangxi Huayi New Materials 750,000 tons/year propylene and downstream deep processing integration project ushered in the first commissioning -- the acrylic device was officially commissioned at 15:38, which marked the transition from project construction to production and operation of Guangxi Huayi New Materials Company.
The production technology of acrylic acid and ester adopts the process technology independently developed by Huayi Group. With a total investment of 2.26 billion yuan, the project will start construction in March 2021, mainly including two sets of 200,000 tons/year acrylic acid and ester devices, one set of 84,000 tons/year refined acid device, one set of 60,000 tons/year commercial acid device, supporting public works and auxiliary facilities.
2026-09-02
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
LyondellBasell Approves Houston Propylene Expansion Project
-
Suspend tariff concessions for some products in Taiwan, involving 12 chemical products
-
Global propylene and polypropylene face oversupply
-
Downstream Consumption Is Acceptable, PP Market is Strong in a Narrow Range
-
After Bottoming Out for The Past Two Weeks, Can Propylene Usher in a New Wave of Rising Sentiment?
-
Propylene Rise And Fall Forecast
-
Market Analysis - Weekly Report - April 6th to April 8th, 2022- Hot Products
-
Market Analysis - Monthly Report - March 2022- Hot Products
-
BASF Warns That The World's Largest Chemical Base May Be Closed! Shell Emergency Shutdown of Ethylene / Propylene Cracker!
-
YNCC All Parked! Involving Ethylene, Propylene, Toluene, Pure Benzene And Other Products!
Recommend Reading
-
Middle East Conflict Exposes Fragility of Global Fertilizer Supply Chains
-
Chevron Opens Oilfield Chemical Technology to Rivals
-
Stahl Reopens Ranipet Plant
-
South Korea Retires 1.39 Million Tonnes of Ethylene Capacity as Northeast Asia’s Petrochemical Reset Turns Real
-
US-Iran Conflict Escalates Again as Oil Tops $90 and Petrochemical Feedstock Risks Return
-
Vera’s New Kidney Drug Wins FDA Approval, Carrying a $425,000 Annual Price
-
Bayer and Syngenta Score Consecutive Regulatory and Legal Wins in the U.S.
-
South Korea Expands Mandatory GMO Labeling to Highly Processed Foods
-
Business Society’s Market Outlook for Caustic Soda on August 31, 2026: Consolidation and Volatility
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies